Vanette McLennan1,2, Dominika Ludvik3, Suzanne Chambers3,4,5,6, Mark Frydenberg7. 1. Menzies Health Institute Queensland, Griffith University, Southport, QLD, Australia. v.mclennan@griffith.edu.au. 2. School of Allied Health Sciences, Griffith University, Southport, QLD, Australia. v.mclennan@griffith.edu.au. 3. Menzies Health Institute Queensland, Griffith University, Southport, QLD, Australia. 4. University of Technology Sydney, Sydney, NSW, Australia. 5. Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia. 6. Institute for Resilient Regions, University of Southern Queensland, Toowoomba, QLD, Australia. 7. Department of Surgery, Monash University, Clayton, Australia.
Abstract
PURPOSE: Research in the field of vocational rehabilitation, specifically for prostate cancer, remains rare despite increasing recognition of the role of vocational interventions in other cancer groups. The aim of this review was to compile and evaluate current trends, facilitators and barriers associated with returning to work after a prostate cancer diagnosis. METHOD: The literature search was conducted in March 2018 using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Forty-seven original research papers published in English in peer-reviewed journals were identified. The included studies comprised a total of 20,083 prostate cancer patients with a mean age of 61 years. RESULTS: The studies implied a good overall return to work prognosis in prostate cancer patients; however, these findings are not generalisable to those with physically demanding or low paid jobs, comorbid conditions or poor physical functioning. CONCLUSION: The limited research investigating the long-term implications of prostate cancer indicates that there may be problems related to job retention and early unwanted retirement. Facilitators and barriers to employment after prostate cancer are identified and implications for vocational interventions and further research are discussed. IMPLICATIONS FOR CANCER SURVIVORS: This review helps to shed light on the barriers and facilitators to employment among prostate cancer survivors, as well as the need for further research and development in vocational rehabilitation interventions for this population.
PURPOSE: Research in the field of vocational rehabilitation, specifically for prostate cancer, remains rare despite increasing recognition of the role of vocational interventions in other cancer groups. The aim of this review was to compile and evaluate current trends, facilitators and barriers associated with returning to work after a prostate cancer diagnosis. METHOD: The literature search was conducted in March 2018 using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Forty-seven original research papers published in English in peer-reviewed journals were identified. The included studies comprised a total of 20,083 prostate cancerpatients with a mean age of 61 years. RESULTS: The studies implied a good overall return to work prognosis in prostate cancerpatients; however, these findings are not generalisable to those with physically demanding or low paid jobs, comorbid conditions or poor physical functioning. CONCLUSION: The limited research investigating the long-term implications of prostate cancer indicates that there may be problems related to job retention and early unwanted retirement. Facilitators and barriers to employment after prostate cancer are identified and implications for vocational interventions and further research are discussed. IMPLICATIONS FOR CANCER SURVIVORS: This review helps to shed light on the barriers and facilitators to employment among prostate cancer survivors, as well as the need for further research and development in vocational rehabilitation interventions for this population.
Entities:
Keywords:
Employment; Prostate cancer; Return to work; Vocational rehabilitation; Work
Authors: Reuben Escorpizo; Michiel F Reneman; Jan Ekholm; Julie Fritz; Terry Krupa; Sven-Uno Marnetoft; Claude E Maroun; Julietta Rodriguez Guzman; Yoshiko Suzuki; Gerold Stucki; Chetwyn C H Chan Journal: J Occup Rehabil Date: 2011-06
Authors: M-L Lindbohm; T Taskila; E Kuosma; P Hietanen; K Carlsen; S Gudbergsson; H Gunnarsdottir Journal: J Cancer Surviv Date: 2011-11-02 Impact factor: 4.442
Authors: K Robin Yabroff; William F Lawrence; Steven Clauser; William W Davis; Martin L Brown Journal: J Natl Cancer Inst Date: 2004-09-01 Impact factor: 13.506
Authors: Angela G E M de Boer; Taina Taskila; Anneli Ojajärvi; Frank J H van Dijk; Jos H A M Verbeek Journal: JAMA Date: 2009-02-18 Impact factor: 56.272
Authors: Erin K Tagai; Shawna V Hudson; Michael A Diefenbach; Jenny Xu; Alicja Bator; Allison Marziliano; Suzanne M Miller Journal: J Cancer Surviv Date: 2020-07-18 Impact factor: 4.442
Authors: Mary Lucy Marques; Alessia Alunno; Sofia Ramiro; Polina Putrik; Annelies Boonen; Marieke M Ter Wee; Louise Falzon Journal: RMD Open Date: 2021-02
Authors: Anneke Ullrich; Hilke Maria Rath; Ullrich Otto; Christa Kerschgens; Martin Raida; Christa Hagen-Aukamp; Corinna Bergelt Journal: Support Care Cancer Date: 2021-08-15 Impact factor: 3.603
Authors: Benjamin Shemesh; Jacinta Opie; Ellie Tsiamis; Darshini Ayton; Prassannah Satasivam; Paula Wilton; Karla Gough; Katrina Lewis; Colin O'Brien; Max Shub; Amanda Pomery; Christopher Mac Manus; Jeremy Millar; Susan Evans Journal: Health Expect Date: 2022-04-11 Impact factor: 3.318